Trial reportAesthetic plastic surgery2026
Cell Salvage in Liposuction, a Safety Tool in a New Surgical Scenario.
Trial report in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe improvement in liposuction and associated procedures seen in recent years has led to an increase in complications, particularly related to significant blood loss. This study aims to evaluate the intraoperative use of cell salvage to recover red blood cells from liposuction aspirate and reinfuse them into the patient.
methodsA prospective, randomized, blinded and controlled trial was conducted with 63 patients.
resultsPostoperative hematocrit (HT) was significantly higher in the intervention group (34.8 ± 3.3) compared to the control group (31.1 ± 2.7, p < 0.001). Similarly, hemoglobin (Hb) levels were greater 24 hours after surgery (11.7 ± 1.1 vs 10.4 ± 0.8, p < 0.001). On average, 198.5 mL (198.50 ± 136.60) of red blood cells were recovered and reinfused.
conclusionPatient blood management is a key strategy to enhance surgical outcomes globally. The use of cell salvage during liposuction helps preserve hemoglobin levels close to normal ranges and prevent acute anemia, contributing to faster and safer recovery. Cell salvage should be considered a standard tool and routinely used in extensive liposuction procedures. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41028614What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.